Showing results (151-160 of 160) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Trials|July 27, 2021
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letterGareth O Griffiths, Richard FitzGerald, Thomas Jaki, et al.Lancet (London, England)|May 23, 2016
Late Ebola virus relapse causing meningoencephalitis: a case reportMichael Jacobs, Alison Rodger, David J Bell, et al.The Journal of Antimicrobial Chemotherapy|August 27, 2021
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled studySaye H Khoo, Richard Fitzgerald, Thomas Fletcher, et al.Genome Biology|June 7, 2007
Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strainsLaurence Rohmer, Christine Fong, Simone Abmayr, et al.Lancet (London, England)|October 22, 2017
Evidence-based guidelines for supportive care of patients with Ebola virus diseaseFrançois Lamontagne, Robert A Fowler, Neill K Adhikari, et al.European Heart Journal|February 17, 2021
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonanceTushar Kotecha, Daniel S Knight, Yousuf Razvi, et al.ERJ Open Research|September 23, 2020
Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocolAlexander G Mathioudakis, Fekri Abroug, Alvar Agusti, et al.The European Respiratory Journal|October 15, 2021
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbationsAlexander G Mathioudakis, Fekri Abroug, Alvar Agusti, et al.BMJ (Clinical Research Ed.)|March 2, 2021
A living WHO guideline on drugs to prevent covid-19François Lamontagne, Miriam Stegemann, Arnav Agarwal, et al.BMJ (Clinical Research Ed.)|September 5, 2020
A living WHO guideline on drugs for covid-19Arnav Agarwal, Beverly Hunt, Miriam Stegemann, et al.Pageof 16